Witnessing is an integral part of the administration of controlled drugs. It is a safeguard that improves patient safety by ensuring two people have checked that the administration is correct before giving it to the patient. For the nurses, however, this can be daunting when they need to witness several administrators daily and authenticate each one by typing their username and password into the system.
Dr. Sean Kelly, Chief Medical Officer at Imprivata, said: “Too often, IT security practices can be a barrier to delivering care. At Imprivata, we believe that if IT security doesn’t work for people, then it doesn’t work at all. Our partnership enables fast, secure authentication within the Better Meds Electronic Prescribing and Medicines Administration (ePMA) system, including witness signing for drug administering and other medication workflows. This provides frictionless access, which helps organisations drive adoption of the ePMA system to transform how automated medicines management and electronic prescribing can be used in the delivery of patient care.”
Imprivata is a leading provider of automated authentication solutions for the healthcare industry. Its technology allows for the authentication of key workflows, including registering new patients, entering patient observations, adding clinical notes, and witness signing wherever required.
"We are excited to be partnering with Imprivata on this initiative," said Alastair Allen, Chief Technology Officer at Better. "Their ConfirmID product is helping health and care customers to simplify and streamline clinical authentication workflows. Together, we have developed seamless integration with Better Meds that will make witnessing for medications easier, safer and faster."